As we know, CD8+ T cells exhausted in patients with lung cancer, the PBMCs from the patients with cancer were investigated in terms of the anti-tumor effect in the tumor xenografts (n = 3, P7, P9, and P10 in Table 1, Figure 6C). This evidence concerns the gene CD8A and lung carcinoma.